Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alan V Boddy

6PUBLICATIONS
14CO-AUTHORS
Instruments and techniquesEmergency medicinePharmacogenomicsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jan 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.

Harry J Iland, John Reynolds, Alan V Boddy

|Apr 23, 2022
Physiologically Based Pharmacokinetic Modeling Approaches for Patients With SARS-CoV-2 Infection: A Case Study With Imatinib.

Jeffry Adiwidjaja, Josephine A Adattini, Alan V Boddy

|Jan 20, 2022
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib.

Jeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan

|Sep 18, 2021
Physiologically-based pharmacokinetic model predictions of inter-ethnic differences in imatinib pharmacokinetics and dosing regimens.

Jeffry Adiwidjaja, Annette S Gross, Alan V Boddy

|Apr 07, 2020
Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically-based pharmacokinetic modelling approach.

Jeffry Adiwidjaja, Alan V Boddy, Andrew J McLachlan

|Sep 28, 2018
Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.

J K Duong, G J Veal, C E Nath

Pageof 1

Frequent Collaborators

4 joint publications

Jeffry Adiwidjaja

4 joint publications

Andrew J McLachlan

1 joint publications

J K Duong

1 joint publications

G J Veal

1 joint publications

Annette S Gross

1 joint publications

Josephine A Adattini

1 joint publications

Harry J Iland

1 joint publications

John Reynolds

1 joint publications

Hayley B Schultz

1 joint publications

Steven W Lane

Frequent Collaborators

4 joint publications

Jeffry Adiwidjaja

4 joint publications

Andrew J McLachlan

1 joint publications

J K Duong

1 joint publications

G J Veal

Top Related Videos

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium <em>In Situ</em> Recovery Bleed Water and Its Effect on Cell Viability
09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium <em>In Situ</em> Recovery Bleed Water and Its Effect on Cell Viability

Published on : Jun 21, 2015

9.7K
A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on : Jun 21, 2018

18.9K
See more related videos

Top Related Videos

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium <em>In Situ</em> Recovery Bleed Water and Its Effect on Cell Viability
09:23

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium <em>In Situ</em> Recovery Bleed Water and Its Effect on Cell Viability

Published on : Jun 21, 2015

9.7K
A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered <em>In Vitro</em>/<em>In Silico</em> Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on : Apr 06, 2016

10.3K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on : Jun 21, 2018

18.9K
See more related videos